Risk factors for mortality in hospitalized patients infected with carbapenem-resistant Pseudomonas aeruginosa in Iran
- PMID: 37680680
- PMCID: PMC10482481
- DOI: 10.18683/germs.2022.1338
Risk factors for mortality in hospitalized patients infected with carbapenem-resistant Pseudomonas aeruginosa in Iran
Abstract
Introduction: Mortality due to carbapenem-resistant Pseudomonas aeruginosa (CRPA) infection has increased worldwide in recent years. The risk factors associated with hospital settings in Iran and the role of strain resistance mechanisms in many studies are unclear.
Methods: A retrospective study was conducted on consecutive non-repetitive patients with CRPA infections isolated from seven major hospitals from northwest of Iran. We evaluated different risk factors and characteristics of bacteria for the death or survival of patients.
Results: In this study, 116 CRPA isolates were obtained from patients admitted to seven hospitals. Forty-one (35.3%) patients were enrolled in the study of mortality risk factors. Significant risk factors associated with mortality included the site of infection, hospitalization in different wards, the use of invasive devices, and the type of carbapenem resistance mechanisms.
Conclusions: ICU admission, the use of mechanical ventilation and chest tube and infection with pandrug-resistant strains were the most important factors in increasing mortality due to CRPA infection. These results suggested that the clinicians should emphasize the proper use of antibiotic and invasive procedures.
Keywords: Carbapenem; Pseudomonas aeruginosa; mortality; risk factor.
GERMS.
Conflict of interest statement
Conflicts of interest: All authors – none to declare.
Figures
Similar articles
-
Carbapenem-resistant Pseudomonas aeruginosa infections in critically ill children: Prevalence, risk factors, and impact on outcome in a large tertiary pediatric hospital of China.Front Public Health. 2023 Feb 9;11:1088262. doi: 10.3389/fpubh.2023.1088262. eCollection 2023. Front Public Health. 2023. PMID: 36844819 Free PMC article.
-
Carbapenem Resistant Pseudomonas aeruginosa Infections in Elderly Patients: Antimicrobial Resistance Profiles, Risk Factors and Impact on Clinical Outcomes.Infect Drug Resist. 2022 Apr 29;15:2301-2314. doi: 10.2147/IDR.S358778. eCollection 2022. Infect Drug Resist. 2022. PMID: 35517901 Free PMC article.
-
Evaluation of Carbapenem Resistance Mechanisms and Its Association with Pseudomonas aeruginosa Infections in the Northwest of Iran.Microb Drug Resist. 2018 Mar;24(2):126-135. doi: 10.1089/mdr.2016.0310. Epub 2017 Jun 27. Microb Drug Resist. 2018. PMID: 28654368
-
Prevalence of metallo-β-lactamase-encoding genes among carbapenem-resistant Pseudomonas aeruginosa strains isolated from burn patients in Iran.Rev Soc Bras Med Trop. 2018 May-Jun;51(3):270-276. doi: 10.1590/0037-8682-0044-2018. Rev Soc Bras Med Trop. 2018. PMID: 29972555 Review.
-
[A systematic review and expert's analysis of risk factors of infections in adults due to carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumannii in Spain].Rev Esp Quimioter. 2021 Aug;34(4):298-307. doi: 10.37201/req/034.2021. Epub 2021 Apr 29. Rev Esp Quimioter. 2021. PMID: 33913312 Free PMC article. Spanish.
Cited by
-
Evaluation of Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae in an Intensive Care Unit: A Retrospective Study.Antibiotics (Basel). 2025 Jul 12;14(7):700. doi: 10.3390/antibiotics14070700. Antibiotics (Basel). 2025. PMID: 40724002 Free PMC article.
References
-
- Clinical and Laboratory Standards Institute. Wayne, PA, USA: CLSI; 2015. Performance standards for antimicrobial susceptibility testing. Twenty-fifth informational supplement M100-S25.
LinkOut - more resources
Full Text Sources